HM-279

HM-279 : Inhibitor of TGFBR1

Structure

Information

  • TGFBR1
  • Inhibitor
  • up to 1 uM

In Vitro Validations

Uniprot ID: P36897
Target Class: Kinase
Target SubClass: TKL
Potency: IC50
Potency Value: 4.7 nM
Potency Assay: Biochemical assay
PDB ID for probe-target interaction (3D structure): 9J9D
Target aliases:
TGF-beta receptor type-1, TGFBR1, TGFR1_HUMAN, Tbe ...

DOI Reference: 10.1021/acs.jmedchem.4c02293

In Cell Validations

In Vivo Data

Off-Target Selectivity Assesments

Off Target: ACVR1C
Potency end-point : IC50 6.8 nM
Potency assay (off target): HM-279 was evaluated in a panel of 10 TGF-β receptor family kinases. HM-279 showed cross-reactivity with ALK7 (IC50 = 6.8 nM), but has fair to good selectivity against other TGF-β receptor family members, with 4.5–693-fold selectivity. 16 fold selectivity over TrkC and 24 fold selectivity over AurC kinases.
Potency assay (off target): Kinome-wide selectivity of HM-279 was also assessed in a panel of 255 kinase assays. HM-279 exhibited an excellent kinase selectivity and inhibited only 9 kinases: AurA, BUB1/BUB3, FLT4, KDR, NuaK1, PDGFRα, PDGFRβ, QIK, and MST1 (>70% inhibition at 0.1 μM).
I have extra information to add

SERP ratings and comments


No SERP comments found for HM-279